Copyright
©The Author(s) 2025.
World J Diabetes. May 15, 2025; 16(5): 103511
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.103511
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.103511
Figure 6 Shenzhuo formulation attenuates inflammatory responses and oxidative stress levels via cytochrome P450-mediated arachidonic acid metabolism, which ameliorates renal injury in diabetic nephropathy mice.
DN: Diabetic nephropathy; IL-1β: Interleukin-1β; IL-6: Interleukin-6; TNF-α: Tumor necrosis factor-α; SOD: Superoxide dismutase; GSH-Px: Glutathione peroxidase; MDA: Malondialdehyde (Created by FigDraw).
- Citation: Zhang ZY, Wang YM, Wang N, Wang YS, Zhang H, Wang D, Wang LX, Cui HT, Wen WB, Lv SQ, Cao YJ. Shenzhuo formulation ameliorates diabetic nephropathy by regulating cytochrome P450-mediated arachidonic acid metabolism. World J Diabetes 2025; 16(5): 103511
- URL: https://www.wjgnet.com/1948-9358/full/v16/i5/103511.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i5.103511